MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Undifferentiated Pleomorphic Sarcoma

  1. Home
  2. Diseases
  3. Undifferentiated Pleomorphic Sarcoma
  4. Clinical Trials

Clinical Trials Related to Undifferentiated Pleomorphic Sarcoma

Related studies linked through entity extraction aliases.

NCT03425279

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT03307616

Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2

NCT02923778

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2

NCT02584309

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Status
COMPLETED
Phase
PHASE2

NCT02565758

ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors

Status
COMPLETED
Phase
PHASE1
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.